Factbox: The Galapagos drugs pipeline that has drawn in Gilead

(Reuters) – U.S. antiviral drugmaker Gilead Sciences (GILD.O) will invest $5.1 billion in a major expansion of its partnership with Belgo-Dutch biotech Galapagos NV (GLPG.AS). A Gilead Sciences, Inc. logo is seen outside the company headquarters in Foster City, California, U.S. May 1, 2018. REUTERS/Stephen LamThe following is an overview of Galapagos’s drugs pipeline. FILGOTINIB…

How 3 Words Helped Change This Man’s Career

The founder of this biotech company explains how he was able to change careers and pinpoint his passion. July 17, 2019 2 min read Opinions expressed by Entrepreneur contributors are their own. In this video, Entrepreneur Network partner Mars Discovery District speaks with Carlo Perez about when he realized he could achieve more than his current…

Ment.io wants to help your team make decisions

Getting even the most well-organized team to agree on anything can be hard. Tel Aviv’s Ment.io, formerly known as Epistema, wants to make this process easier by applying smart design and a dose of machine learning to streamline the decision-making process. Like with so many Israeli startups, Ment.io’s co-founders Joab Rosenberg and Tzvika Katzenelson got…

A $4.5 billion biotech working on tech-driven cancer treatments told us how it’s using AI in areas rivals are ignoring, and why companies that aren’t could struggle

For biotech company Moderna, which went public last year in the biggest biotech IPO in history, the emphasis is as much on the tech as the biology. That extends from the tablets that monitor operations on the floor of its Norwood, Massachusetts manufacturing facility to the algorithms that are used in its experimental cancer vaccines.…

Swiss drug giant Novartis has done $60 billion in deals over the past 18 months. One sentence from its CEO reveals the core strategy. (NVS)

When Vas Narasimhan started as the new CEO of the Swiss drug giant Novartis, he began refocusing the company on a key business area: prescription medicines. Until recently, alongside top-selling psoriasis, multiple sclerosis, and vision-loss drugs, Novartis was also making contact lenses and skin products, and it even had a hand in consumer-health products like…

A startup led by a former Google exec and a pioneering scientist just raised $2.8 million to tackle a little-understood condition that affects 10 million people

A new startup is betting that studying the vaginal microbiome — a collection of bacteria in the vagina — could hold the key to a variety of women’s health conditions. The biotech, LUCA Biologics, is focusing first on urinary tract infections, a common problem among women that accounts for an estimated 10 million doctors visits…

Video: a look at how the masterful images were captured for the ‘I Spy’ book series

Do you remember the I Spy book series? You know, the books that cleverly composed countless objects in an image to provide a seemingly never-ending game of hide-and-seek. Well, each of those images were meticulously crafted by photo illustrator Walter Wick and YouTube channel Insider has shared a behind-the-scene video that takes a look at…